INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements.

about

INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements.

Item

http://www.wikidata.org/entity/Q54216584

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

INASL Position Statements on P ...... India: The Andaman Statements.

@en

INASL Position Statements on P ...... India: The Andaman Statements.

@nl

type

Item

label

INASL Position Statements on P ...... India: The Andaman Statements.

@en

INASL Position Statements on P ...... India: The Andaman Statements.

@nl

prefLabel

INASL Position Statements on P ...... India: The Andaman Statements.

@en

INASL Position Statements on P ...... India: The Andaman Statements.

@nl

P1476

INASL Position Statements on P ...... India: The Andaman Statements.

@en

P2093

Anil Arora

http://www.w3.org/2001/XMLSchema#string

Ashish Goel

http://www.w3.org/2001/XMLSchema#string

Bhabadev Goswami

http://www.w3.org/2001/XMLSchema#string

Dharmesh Kapoor

http://www.w3.org/2001/XMLSchema#string

Gaurav Pandey

http://www.w3.org/2001/XMLSchema#string

Harshad Devarbhavi

http://www.w3.org/2001/XMLSchema#string

INASL Hepatitis B Taskforce

http://www.w3.org/2001/XMLSchema#string

Jimmy Narayan

http://www.w3.org/2001/XMLSchema#string

Kaushal Madan

http://www.w3.org/2001/XMLSchema#string

Manav Wadhawan

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers

Grading quality of evidence and strength of recommendations

Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep)

CDC guidance for evaluating health-care personnel for Hepatitis B virus protection and for administering postexposure management

Prevention of Hepatitis B reactivation in the setting of immunosuppression

KASL clinical practice guidelines: management of chronic hepatitis B

The option of HBIG-free prophylaxis against recurrent HBV

Is hepatitis B immunoglobulin necessary in prophylaxis of hepatitis B recurrence after liver transplantation? A meta-analysis

Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India

Management of patients with hepatitis B in special populations

P304

58-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCEH.2017.12.001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ashish Kumar

Shalimar

P577

2017-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29743798

http://www.w3.org/2001/XMLSchema#string

P921

India

P932

5938334

http://www.w3.org/2001/XMLSchema#string